MedPath

Machine Learning Based-Personalized Prediction of Sperm Retrieval Success Rate

Completed
Conditions
Infertility, Male
Azoospermia, Nonobstructive
Interventions
Diagnostic Test: Machine learning-based predictive model
Registration Number
NCT06358794
Lead Sponsor
Peking University Third Hospital
Brief Summary

Non-obstructive azoospermia (NOA) stands as the most severe form of male infertility. However, due to the diverse nature of testis focal spermatogenesis in NOA patients, accurately assessing the sperm retrieval rate (SRR) becomes challenging. The current study aims to develop and validate a noninvasive evaluation system based on machine learning, which can effectively estimate the SRR for NOA patients. In single-center investigation, NOA patients who underwent microdissection testicular sperm extraction (micro-TESE) were enrolled: (1) 2,438 patients from January 2016 to December 2022, and (2) 174 patients from January 2023 to May 2023 (as an additional validation cohort). The clinical features of participants were used to train, test and validate the machine learning models. Various evaluation metrics including area under the ROC (AUC), accuracy, etc. were used to evaluate the predictive performance of 8 machine learning models.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
2612
Inclusion Criteria
  • diagnosed with nonobstructive azoospermia
  • underwent microdissection testicular sperm extraction
Read More
Exclusion Criteria
  • without intact clinical information
  • low data quality
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Training cohortMachine learning-based predictive model2,438 patients diagnosed with NOA were included for model training and validation
Primary Outcome Measures
NameTimeMethod
SRR of micro-TESEAt the time after microdissection testicular sperm extraction

the sperm retrieval success rate of microdissection testicular sperm extraction

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Peking University Third Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath